Sun Pharma Launches First OTC Drug

Mar 04, 2016

Hindustan Times

India’s Sun Pharmaceutical recently rolled out its first OTC drug, antacid Pepmelt, as it leverages the consumer healthcare portfolio acquired in its Ranbaxy Laboratories buy.

Sun has acquired around 15 Ranbaxy OTC products, including big sellers Revital (health supplement) and Volini (analgesic), which made up over 20 percent of Ranbaxy’s sales.

Pepmelt, which involves melt-in-mouth granules, will compete with popular India antacids such as GSK's Eno and Abbott's Digene.

Read the Hindustan Times article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments